Automatic aseptic sampling valve for sampling from enclosed containers
11906402 ยท 2024-02-20
Assignee
Inventors
- David D. Newbold (Bend, OR, US)
- Douglas L. Millard (Bend, OR, US)
- Erwin Y. Yu (Ballwin, MO, US)
- Paul T. Jeffers (Frankfield, IE)
- Jeffrey W. Weber (Portage, MI, US)
Cpc classification
G01N1/2035
PHYSICS
C12M37/00
CHEMISTRY; METALLURGY
C12M33/04
CHEMISTRY; METALLURGY
International classification
C12M1/12
CHEMISTRY; METALLURGY
Abstract
A sample can be collected from an enclosed container by opening a sample collection valve and drawing the sample from the enclosed container. After delivery of the sample out of a fluid flow path, a sanitizing fluid can be directed along the fluid flow path to sanitize the fluid flow path.
Claims
1. An aseptic automatic fluid sampling system, comprising: a variable volume reservoir, wherein the variable volume reservoir comprises diaphragm pump, moveable between a first configuration that defines a first volume for receiving a fluid sample from a container and a second configuration that defines a second volume, the first volume being larger than the second volume, the variable volume reservoir comprising a variable volume reservoir inlet through which the fluid sample is received into the variable volume reservoir, and a variable volume reservoir outlet through which the fluid sample is discharged from the variable volume reservoir; a sample collection valve moveable between an open configuration and a closed configuration, the sample collection valve being coupled to a fluid outlet of the container; a sample delivery flow path beginning at the sample collection valve and extending downstream to the inlet of the variable volume reservoir, the sample collection valve being in fluid connection with the inlet of the variable volume reservoir when the sample collection valve is in the open configuration; a three-way valve upstream of the sample collection valve, the three-way valve being operable at a first position that permits the flow of a sanitizing fluid through the three-way valve, the three-way valve being operable at a second position that permits the flow of a purge fluid through the three-way valve, forming a purge fluid delivery flow path; and the three-way valve being operable at a third position that restricts the flow of both the sanitizing fluid and of the purge fluid through the three-way valve; the three-way valve being positioned to receive the sanitizing fluid from a sanitizing fluid source separate from the container; an outlet valve positioned downstream of the variable volume reservoir outlet, the outlet valve being moveable between an open configuration and a closed configuration; wherein the sample collection valve is upstream of the variable volume reservoir; and a sanitizing fluid flow path beginning at the three-way valve and extending downstream at least between the three-way valve and the inlet of the variable volume reservoir, the sanitizing fluid flow path completely overlapping the sample delivery flow path, wherein movement of the variable volume reservoir from the first configuration to the second configuration causes the fluid sample to be drawn aseptically and discharged from the variable volume reservoir, and wherein, when the sample collection valve is in the closed configuration and the three-way valve is in the first position, the sanitizing fluid flow path extends downstream at least from the three-way valve to the sample collection valve and from the sample collection valve to the inlet of the variable volume reservoir, and the sample collection valve is in fluid connection with the inlet of the variable volume reservoir so the sample delivery flow path may be sanitized frequently.
2. The aseptic automatic fluid sampling system of claim 1, wherein, when the sample collection valve is in the closed configuration and the three-way valve is in the second position, the purge fluid delivery flow path extends at least from the three-way valve to the sample collection valve and from the sample collection valve to the variable volume reservoir.
3. The aseptic automatic fluid sampling system of claim 1, further comprising a control valve positioned downstream of the outlet valve.
4. The aseptic automatic fluid sampling system of claim 3, wherein the control valve comprises a variable back-pressure regulator.
5. The aseptic automatic fluid sampling system of claim 3, wherein the control valve comprises a thermostatically-controlled valve.
6. The aseptic automatic fluid sampling system of claim 1, wherein the variable volume reservoir comprises a flexible diaphragm member and a housing with a first area and a second area, the flexible diaphragm member being configured to move between a first position where a first surface of the flexible diaphragm member contacts the first area of the housing and a second position where a second surface of the flexible diaphragm member contacts the second area of the housing.
7. The aseptic automatic fluid sampling system of claim 6, wherein the first surface of the flexible diaphragm member is generally opposite the second surface of the flexible diaphragm member.
8. The aseptic automatic fluid sampling system of claim 6, wherein the flexible diaphragm member comprises a generally spherical housing and the first area is a first half of the generally spherical housing and the second area is a second half of the generally spherical housing, wherein the second surface contacts the second half of the generally spherical housing when in the second position, the flexible diaphragm member being generally inverted when in the second position, relative to its orientation when in the first position.
9. The aseptic automatic fluid sampling system of claim 1, wherein the sample collection valve comprises a valve stem with a tapered sealing member that moves from a first position when the sample collection valve is in the open configuration to a second position when the sample collection valve is in the closed configuration, wherein a portion of the valve stem extends into the sanitizing fluid flow path when the sample collection valve is in the second position.
10. The aseptic automatic fluid sampling system of claim 1, wherein the sample collection valve, and the three-way valve are contained within a single housing.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)
DETAILED DESCRIPTION
(27) Various embodiments of sampling systems and their methods of use are disclosed herein. The following description is exemplary in nature and is not intended to limit the scope, applicability, or configuration of the invention in any way. Various changes to the described embodiment may be made in the function and arrangement of the elements described herein without departing from the scope of the invention.
(28) As used in this application and in the claims, the singular forms a, an, and the include the plural forms unless the context clearly dictates otherwise. Additionally, the term includes means comprises. Further, the term coupled generally means electrically, electromagnetically, and/or physically (e.g., mechanically or chemically) coupled or linked and does not exclude the presence of intermediate elements between the coupled or associated items absent specific contrary language.
(29) The terms upstream and downstream are not absolute terms; instead, those terms refer to the direction of flow of fluids within a channel or pathway. Thus, with regard to a structure through which a fluid flows, a first area is upstream of a second area if the fluid flows from the first area to the second area. Likewise, the second area can be considered downstream of the first area.
(30) Unless otherwise indicated, all numbers expressing quantities of ingredients, properties such as molecular weight, percentages, measurements, distances, ratios, and so forth, as used in the specification or claims are to be understood as being modified by the term about. Accordingly, unless otherwise indicated, implicitly or explicitly, the numerical parameters set forth are approximations that may depend on the desired properties sought and/or limits of detection under standard test conditions/methods. When directly and explicitly distinguishing embodiments from discussed prior art, the embodiment numbers are not approximates unless the word about is recited.
(31) Although the operations of exemplary embodiments of the disclosed method may be described in a particular, sequential order for convenient presentation, it should be understood that disclosed embodiments can encompass an order of operations other than the particular, sequential order disclosed. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Further, descriptions and disclosures provided in association with one particular embodiment are not limited to that embodiment, and may be applied to any embodiment disclosed.
(32)
(33) The samples that are dispensed from outlet 108 for analysis or processing are desirably representative of the materials in bioreactor 102 at the time the sample was taken. To reduce the risk of contamination, dilution, or alteration of the composition of the samples taken from sample collection valve 104 and delivered through flow path 106, a sanitizing fluid can be delivered through a portion of flow path 106 that comes into contact with the samples.
(34) To introduce the sanitizing fluid into flow path 106, a sanitizing fluid inlet valve 114 is provided upstream of sample collection valve 104. Sanitizing fluid inlet valve 114 is operable between a closed position that restricts fluid flow through sanitizing fluid inlet valve 114 and an open position that allows fluid flow through sanitizing fluid inlet valve 114. In one embodiment, the sanitizing fluid comprises steam. In some embodiments, some or all of the valves can be biased closed.
(35) In one embodiment, the sanitizing fluid is any fluid that can sanitize, disinfect, or sterilize the valve. The sanitizing fluid can be a liquid, a gas, or a combination thereof. Sanitizing fluids include steam, ethylene oxide, glutaraldehyde, formaldehyde, formalin, chlorine gas, hypochlorite, bromine, hypobromite, iodine, hypoiodite, bromine chloride, chlorine dioxide, ozone, hydrogen peroxide, monochloramine, dichloramine, trichloramine, quatinary ammonium salts, ethanol, 70% ethanol/water, isopropanol, 70% isopropanol/water, peroxyacetic acid, and peracetic acid. In one embodiment, the sanitizing fluid is steam. In another embodiment, the sanitizing fluid is ethylene oxide. In another embodiment, the sanitizing fluid is glutaraldehyde.
(36) A gas inlet valve 116 can also be provided upstream of sample collection valve 104 to deliver a gas through flow path 106. The gas can eliminate and/or reduce the amount of sanitizing fluid remaining within flow path 106 after flow path 106 is exposed to the sanitizing fluid. The sanitizing fluid can clean the path and/or remove any material from previous samples in the area contacted by the sanitizing fluid. Gas inlet valve 116 is operable between a closed position that restricts the flow of gas through gas inlet valve 116 and an open position that allows the flow of gas through gas inlet valve 116. In one embodiment, the gas comprises compressed air.
(37) To draw a sample from bioreactor 102, a variable volume reservoir 118 can be provided downstream of sample collection valve 104. Variable volume reservoir 118 can be moveable between a first position and a second position to draw a sample through sample collection valve 104 and into flow path 106. The sample can be drawn into at least a portion of variable volume reservoir 118 along a first portion of flow path 106 and discharged from variable volume reservoir 118 along a second portion of flow path 106. Variable volume reservoir 118 can comprise a diaphragm pump (as shown in
(38) As shown by dotted lines in
(39)
(40)
(41) Referring now to
(42)
(43) Referring again to
(44)
(45) As shown in
(46) Thus, as diaphragm 140 moves from the first position (
(47) As shown in
(48) Pressure on either side of diaphragm 140 can cause operation of variable volume reservoir in the manners described herein. For example, pressure from the sample source in connection with the delivery of sample 126 from bioreactor 102 through open sample collection valve 104 (see
(49) Similarly, the sample can be expelled from variable volume reservoir 118 by providing pressure on the non-sample contacting surface (i.e., the back side) of diaphragm 140. Such pressure can be provided on the back side of diaphragm 140 by delivering, for example, any fluid towards that surface as indicated, for example, by the origination of the arrow in
(50) Thus, in some embodiments, diaphragm 140 can comprise a flexible, inverting diaphragm that can advantageously provide a system that is capable of performing a pumping action with relatively low amounts of turbulence being introduced to the system. In addition, such a diaphragm is capable of actuation using relatively low pressures, including a relatively low sample inlet pressure to move the diaphragm from the second position (
(51) In some embodiments, the flexible material can have a low gas permeability to ensure the fluid used to expel the sample (e.g., air or nitrogen) doesn't permeate into the sample, thus changing the properties. EPDM can be used for the flexible material. Alternatively, other materials such as Kalrez, Viton, polyethylene, polyurethane, and polypropylene can also be used. The material should be able to withstand the sanitization conditionse.g., steam.
(52)
(53) Sampling system 200 can include a sample collection valve 204, an outlet valve 208, a sanitizing fluid inlet valve 214, and a gas inlet valve 216. One or more of these valves can be configured to have a valve stem 221 and a sealing member 223. Although
(54)
(55) Referring to
(56) Once the gas purges the remaining sanitizing fluid from flow path 206, both the sanitizing fluid inlet valve 214 and the gas inlet valve 216 can close to allow a sample to be drawn into flow path 206. As shown in
(57)
(58) A spring 237 can be provided to bias valve stem 221 towards the closed configuration (
(59)
(60)
(61)
(62) Moreover, by forming sample collection valve with a sealing member 223 that tapers from valve stem 221, the area of contact between sealing member 223 and the opening can be reduced. To provide improved sealing characteristics, in some embodiments, the tip of the valve stem can extend at an angle of greater than 50 degrees from the body of the valve stem and, more preferably at an angle of greater than 70 degrees and, even more preferably at an angle of about 80 degrees.
(63) In some embodiments, sealing member 223 (
(64) In this manner, sealing member 223 can extrude into the seat to form a tighter seal. In addition, as shown in
(65) In some embodiments, the sealing member and valve stem can be formed of the same polymeric material, which can further improve operation by reducing complexities of manufacturing and permitting the sealing member and valve stem component to be more compact.
(66)
(67) As described above with respect to
(68)
(69) Referring again to
(70)
(71) As discussed above, the variable volume reservoirs can include a diaphragm pump or other similar structures.
EXAMPLE
Comparison of Sampling System Valve to Conventional Manual Sampling
(72) An automated aseptic sampling (AAS) system similar to that described above with respect to
(73) For the first comparison test, the AAS system was attached to a 30 L New Brunswick bioreactor (Edison, NJ) containing NS0 culture grown in media. As the AAS was drawing sample through an independent port, manual samples were drawn to provide a sample pair. AAS and manual samples were both introduced to the FLEX autosampler for analysis of pH and carbon dioxide (measuring cell activity). Sample error was defined as the difference between the AAS system and manual sampling for a single sample pair. Errors from the sample pairs were averaged to determine variability. The results are shown in Tables 1 and 2 and demonstrate that the AAS is as accurate as manual sampling.
(74) TABLE-US-00001 TABLE 1 Analysis of pH Results Sample pH pH ID AAS Manual Difference 1 7.196 7.196 0 2 7.183 7.175 0.008 3 7.198 7.181 0.017 4 7.177 7.163 0.014 5 7.182 7.166 0.016 Average Difference 0.011
(75) TABLE-US-00002 TABLE 2 Analysis of Carbon Dioxide Results Sample pCO.sub.2 (mmHg) pCO.sub.2 ID AAS Manual Error (%) 1 58.3 56.9 2.5% 2 60.9 61.3 0.7% 3 57.1 57.3 0.3% 4 59.1 61.1 3.3% 5 57.6 60.9 5.4% Average Difference 2.4%
For the second comparison test, an aliquot of cells was added to a stainless steel cylindrical vessel. The vessel was inverted several times to mix. Automatic samples were taken by the AAS system attached to the bottom of the vessel. Manual samples were removed via pipette through the top of the vessel. Automatic and manual samples were introduced to the FLEX autosampler, and sample pairs were analyzed for comparison. Results in Table 3 demonstrate accurate sampling using the AAS valve of the invention.
(76) TABLE-US-00003 TABLE 3 Cell Count Testing Results Total Density Total Viable Density Viable Sample (cells/mL) Density (cells/mL) Density Viability (%) Viability ID AAS Manual Error AAS Manual Error AAS Manual Error 1 61.31 70.26 12.7% 57.69 65.75 12.3% 94.1 93.6 0.5% 2 31.43 33.15 5.2% 29.58 31.07 4.8% 94.1 93.7 0.4% 3 125.38 135.66 7.6% 119.89 128.86 7.0% 95.6 95 0.6% 4 136.08 133.63 1.8% 124.73 123.13 1.3% 91.7 92.1 0.4% 5 125.35 141.11 11.2% 116.34 130.05 10.5% 92.8 92.2 0.7% 6 71.15 72.52 1.9% 64.6 66.17 2.4% 90.8 91.2 0.4% 7 36.14 36.93 2.1% 32.23 33.32 3.3% 89.2 90.2 1.1% 8 126.45 141.59 10.7% 116.61 130.89 10.9% 92.2 92.4 0.2% 9 135.59 137.99 1.7% 126.65 127.56 0.7% 93.4 92.4 1.1% 10 147.26 135.35 8.8% 136.28 125.44 8.6% 92.5 92.7 0.2% 11 80.75 72.54 11.3% 69.36 66.31 4.6% 85.9 91.4 6.0% 12 153.91 135.63 13.5% 133.44 124.65 7.1% 86.7 91.9 5.7% 13 137.91 137.47 0.3% 127.28 125.68 1.3% 92.3 91.4 1.0% 14 62.96 72.34 13.0% 57.38 64.81 11.5% 91.1 89.6 1.7% 15 38.68 40.28 4.0% 34.54 35.06 1.5% 89.3 87 2.6% 16 139.07 143.25 2.9% 128.15 130.79 2.0% 92.1 91.3 0.9% 17 74.44 73.56 1.2% 67.49 66.72 1.2% 90.7 90.7 0.0% 18 32.98 36.93 10.7% 30.21 32.91 8.2% 91.6 89.1 2.8% 19 147.19 136.29 8.0% 138.86 126.41 9.8% 94.3 92.7 1.7% 20 131.98 135.08 2.3% 122.34 124.3 1.6% 92.7 92 0.8% Average 6.5% 5.5% 1.4% Error *Note: NS0 cells grown in fed-batch culture were removed from bioreactor just prior to addition into sampling vessel.
(77) The prototype AAS system of the invention was further tested to demonstrate long-term operation and removal of representative bioreactor samples without bioreactor contamination. The AAS system was mounted on a 30-L bioreactor and tested, using the test schematic noted above, which is similar to that shown in
(78) Additional tests of the AAS/Flex autosampler were performed at the 30-L scale. At a scheduled time point, the AAS system transferred a sample from the bioreactor to the FLEX and commanded the FLEX to take the delivered sample and analyze it. It then cleaned and sanitized itself in preparation for the next sample. A manual sample was taken within about 15 minutes of the automated sample. Cell density and viability measurements from the AAS/Flex autosampler were compared to measurements from manual sampling, to demonstrate that the AAS/Flex autosampler results are in agreement with results obtained from manual samples. Comparison of results in Table 4 shows accurate sampling using the AAS valve of the invention.
(79) TABLE-US-00004 TABLE 4 Cell Count Performance of the AAS/Flex Autosampler @ 30 L Scale Viable Cell Density (1E6 cells/mL) % Viability (%) % Day AAS Manual Difference AAS Manual Difference 0.00 0.70 n/a n/a 96.90 n/a n/a 0.37 0.87 0.80 8.06 98.70 98.90 0.20 0.82 1.02 0.88 13.78 99.00 99.00 0.00 1.84 2.05 1.67 18.60 99.40 99.20 0.20 3.06 3.55 3.54 0.28 98.10 98.40 0.30 3.40 4.58 4.38 4.47 98.40 98.20 0.20 3.83 5.19 4.55 12.39 98.80 98.80 0.00 4.10 5.94 5.93 0.29 98.70 98.70 0.00 4.41 6.65 6.20 6.79 98.90 98.90 0.00 4.80 7.15 7.51 5.14 99.30 99.10 0.20 5.42 9.18 8.64 5.91 99.10 98.80 0.30 5.80 10.05 9.93 1.13 99.30 99.10 0.20 6.08 11.70 11.32 3.26 99.20 99.20 0.00 6.39 11.78 11.20 4.92 99.20 99.20 0.00 6.80 12.39 12.13 2.10 98.80 98.90 0.10 7.10 13.13 13.71 4.42 98.30 98.20 0.10 7.38 14.30 12.34 13.72 98.00 98.10 0.10 7.86 14.59 14.63 0.29 98.20 98.00 0.20 8.93 15.06 14.72 2.27 96.80 96.60 0.20 9.78 14.93 15.10 1.11 95.20 95.30 0.10 10.11 14.86 15.28 2.79 94.90 94.10 0.80 10.40 14.69 15.40 4.83 94.70 93.90 0.80 11.91 14.05 14.24 1.30 92.70 93.00 0.30 12.70 13.16 12.84 2.44 91.00 91.50 0.50 13.77 12.05 12.21 1.29 87.40 89.50 2.10 Average 5.07% 0.29% % Difference
(80) Results in Table 5 show pH measurements of samples taken using the AAS/Flex autosampler compared to measurements from manual sampling. Table 5 further demonstrates accurate sampling using the AAS valve of the invention.
(81) TABLE-US-00005 TABLE 5 pH Performance of the AAS/Flex Autosampler @ 30 L Scale pH Day AAS Manual Difference 0.37 7.232 7.221 0.011 0.82 7.221 7.241 0.02 1.84 7.171 7.227 0.056 3.06 6.93 6.943 0.013 3.4 6.936 6.952 0.016 3.83 6.927 6.95 0.023 4.1 6.922 6.943 0.021 4.41 6.927 6.945 0.018 4.8 6.918 6.929 0.011 5.42 6.917 6.951 0.034 5.8 6.906 6.924 0.018 6.08 6.894 6.942 0.048 6.39 6.903 6.943 0.04 6.8 6.915 6.932 0.017 7.1 6.912 6.955 0.043 7.38 6.938 6.995 0.057 7.86 6.971 7.003 0.032 8.93 7.01 7.056 0.046 9.78 7.018 7.066 0.048 10.11 7.035 7.088 0.053 10.40 7.042 7.102 0.06 11.91 7.116 7.161 0.045 13.77 7.077 7.119 0.042 Average Unit 0.034 of Difference
(82) Results in Table 6 show pCO.sub.2 measurements of samples taken using the AAS/Flex autosampler compared to measurements from manual sampling. Table 6 further demonstrates accurate sampling using the AAS valve of the invention.
(83) TABLE-US-00006 TABLE 6 pCO.sub.2 Performance of the AAS/Flex Autosampler @ 30 L Scale pH Day AAS Manual % Difference 0.37 69.6 70.8 1.72 0.82 64.7 60.4 6.65 1.84 43.0 35.6 17.21 3.06 27.0 25.5 5.56 3.40 30.7 29.1 5.21 3.83 36.9 31.7 14.09 4.10 36.9 38.1 3.25 4.41 39.6 37.8 4.55 4.80 42.2 40.8 3.32 5.42 42.6 38.9 8.69 5.80 42.5 41.6 2.12 6.08 42.9 41.2 3.96 6.39 47.5 42.3 10.95 6.80 47.5 45.9 3.37 7.10 48.1 47.0 2.29 7.38 47.3 39.9 15.64 7.86 46.8 45.8 2.14 8.93 48.7 42.2 13.35 9.78 49.0 46.5 5.10 10.11 49.6 46.8 5.65 10.40 51.4 48.4 5.84 11.91 58.2 51.1 12.20 12.70 76.7 73.7 3.91 13.77 95.9 88.3 7.92 Average % 6.86 Difference
(84) Results in Table 7 show osmolarity measurements of samples taken using the AAS/Flex autosampler compared to measurements from manual sampling. Table 7 further demonstrates accurate sampling using the AAS valve of the invention.
(85) TABLE-US-00007 TABLE 7 Osmolarity Measurement of the AAS/Flex Autosampler @ 30 L Scale pH Day AAS Manual % Difference 0.37 351 329 6.27 0.82 349 325 6.88 1.84 342 306 10.53 3.06 348 352 1.15 3.4 354 327 7.63 3.83 362 341 5.80 4.1 366 360 1.64 4.41 370 343 7.30 4.8 375 374 0.27 5.8 379 375 1.06 6.08 381 380 0.26 6.39 380 356 6.32 6.8 383 376 1.83 7.1 382 375 1.83 7.38 380 350 7.89 7.86 385 378 1.82 8.93 377 344 8.75 9.78 373 377 1.07 10.11 375 371 1.07 10.40 376 373 0.80 11.91 380 383 0.79 13.77 388 396 2.06 Average % 3.77 Difference
(86) Exemplary Applications of Various Systems and Methods Disclosed Herein
(87) As described herein, optimal production in bioreactors requires regular sampling for off-line analysis to ensure the process remains within the desired operating space for maximum product production. The automated valve disclosed herein, the Automated, Aseptic Sampling (AAS) system can provide rapid, closed-cycle sampling of the bioreactor, steam-in-place (SIP) sterilization between samples, and direct sample delivery to an analyzer. The AAS not only automates and facilitates the sampling process, but can also provide greater reproducibility when compared to manual sampling and has the additional benefits of safety and reliability. The automated sample scheduling and communication with the analytical devices enhances the ability to integrate with process control strategies.
(88) The AAS was installed on 30-L and 130-L bioreactors. Samples were collected using the sampling system and analyzed using a NOVA Flex analyzer (Waltham, Mass.). Outputs from the analyzer included viable cell concentration, cell viability, glucose, pH, partial pressure of carbon dioxide, and osmolality. The AAS system demonstrated the ability to take 3-20 more samples compared to the conventional manual methods typically used, over long periods of time, without affecting the integrity of the bioreactor process. The system performed more consistently and reliably than when samples were taken manually in the development area and showed improved reproducibility.
(89) Some features of the design of the AAS and its sample cycle (as tested in this example) are provided below.
(90) Design
(91) Compact/self-contained with on-board, closed-cycle, sample pump
(92) Current Good Manufacturing Practice (cGMP) compliant
(93) OPC communication capable for integration with variety of analyzers and devices
(94) Unique valve design
(95) Scheduler with operator-specified sampling intervals
(96) Sample Cycle (<45 minutes)
(97) SIP for sterilization
(98) Cool down followed by condensate purge
(99) Sample draw
(100) Sample dispense to sample-handling device or directly to analytical instrument
(101) In tests with the AAS system, more than 500 samples were taken in a four-week-long test; while more than 150 samples were taken in three, two-week-long tests. In all instances, the system performed more consistently and reliably than when samples were taken manually, and the AAS showed improved reproducibility. No system contamination occurred during these tests. During the one testing period, 99 samples were taken without any impact on the sterility of the bioreactor.
(102) The improved performance of the AAS system over manual sampling makes it desirable for use in bioreactors. The AAS demonstrates reliable contamination-free sampling with greater sample consistency and reproduction when compared to manual samples. This scale-independent, low-cost sampling system, which can be manufactured from cGMP-compliant materials, is capable of frequent sampling to enable more intensive process-control schemes. Savings in labor and process optimization/efficiency can be achieved. Moreover, the highly efficient AAS also has use in disposable systems and downstream applications.
(103) The automated sampling systems described herein can advantageously allow for more frequent collection of data, reduce sampling variation and human error associated with the capturing of samples, and reduce costs by reducing labor requirements associated with manual sampling.
(104) It should be understood that the various steps of the disclosed methods and the various components of the disclosed apparatuses are exemplary and the particular order of steps and arrangement of components can be varied without departing from the scope of the invention. For example,
(105)
(106) In operation, for example, a sanitizing fluid (e.g., steam) can be delivered into fluid flow path 506 via a three-way valve 501 to clean the path and/or remove any material from previous samples in the area contacted by the sanitizing fluid. After the sanitizing step, a purge fluid (e.g., air) can be delivered to the fluid flow path 506 via the same valve 501. Because valve 501 is upstream of sample collection valve 504 (which is, in turn, coupled to the bioreactor 502), the air can eliminate and/or reduce the amount of sanitizing fluid remaining within fluid flow path 506 after fluid flow path 506 is exposed to the sanitizing fluid. Thus, three-way valve 501 is operable between a first position that restricts the flow of air (or other purging fluid) but permits sanitizing fluid to pass through, a second position that permits the flow of air (or other purging fluid) and restricts the passage of sanitizing fluid, and a third position that restricts the flow of both air (or other purging fluid) and the sanitizing fluid.
(107) The remaining operation of the device illustrated in
(108)
(109) As shown in
(110)
(111)
(112) In view of the many possible embodiments to which the principles of the disclosed invention may be applied, it should be recognized that the illustrated embodiments are only preferred examples of the invention and should not be taken as limiting the scope of the invention. Rather, the scope of the invention is defined by the following claims. We therefore claim as our invention all that comes within the scope and spirit of these claims.